Epinephrine 1:100,000 Versus 1:500,000 During Gastric Endoscopic Submucosal Dissection

This prospective, randomized, single-center trial compares two epinephrine concentrations (1:100,000 and 1:500,000) in the submucosal injection solution used during gastric endoscopic submucosal dissection. The study evaluates whether the lower epinephrine concentration can maintain procedural efficiency while reducing epinephrine dose, without compromising hemostatic efficacy or safety. A total of 100 participants are planned.

Trial Details

NCT ID
NCT07920068
Phase
NA
Sponsor
Unidade Local de Saúde do Alto Ave, EPE
Status
RECRUITING
Cancer Type
Gastric Cancer
Interventions
  • Epinephrine 1:100,000
  • Epinephrine 1:500,000
Locations (sample)
  • Guimarães, Braga District, Portugal|41.44443,-8.29619

Key Eligibility Criteria

  • Age 18 years or older.
  • Patients scheduled to undergo gastric endoscopic submucosal dissection (ESD) for a dysplastic or neoplastic gastric lesion.
  • Ability to provide written informed consent for participation in the study.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →